{"id":76489,"date":"2025-05-22T10:34:00","date_gmt":"2025-05-22T06:34:00","guid":{"rendered":"https:\/\/www.middleeastevents.com\/blog\/?p=76489"},"modified":"2025-05-27T10:35:41","modified_gmt":"2025-05-27T06:35:41","slug":"globalpharma-inks-4-strategic-mous-during-make-it-in-the-emirates-2025-to-boost-pharma-localization-and-innovation-in-the-uae","status":"publish","type":"post","link":"https:\/\/www.middleeastevents.com\/blog\/globalpharma-inks-4-strategic-mous-during-make-it-in-the-emirates-2025-to-boost-pharma-localization-and-innovation-in-the-uae\/","title":{"rendered":"Globalpharma Inks 4 Strategic MoUs During \u2018Make It In The Emirates 2025\u2019 To Boost Pharma Localization And Innovation In The UAE"},"content":{"rendered":"\n

Globalpharma, <\/a>the UAE\u2019s<\/a> leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai<\/a> Investments PJSC, has signed 4 strategic Memorandums of Understanding (MoUs) during the Make it in the Emirates Forum 2025. The agreements reinforce the UAE\u2019s<\/a> position as a regional hub for pharmaceutical innovation, localization, and advanced healthcare manufacturing.<\/p>\n\n\n\n

The MoUs were signed individually with each partner, reflecting Globalpharma\u2019s tailored approach to strategic collaboration. The agreements were concluded with four international players \u2014 PharmaPrimes Laboratories (Jordan), Nerhadou International (Egypt), Aora Health (Spain), and BioSyent Pharma Inc. (Canada). His Excellency Dr. Thani Al Zeyoudi, UAE Minister of State for Foreign Trade and Chairman of the Emirates Drug Establishment witnessed the signing ceremonies with PharmaPrimes Laboratories, Nerhadou International, and Aora Health. These partnerships span critical areas such as technology transfer, product licensing, supply, and local manufacturing. Aligned with the UAE\u2019s industrial strategy, the collaborations aim to bolster domestic production, reduce reliance on imports, and accelerate access to next-generation healthcare solutions across the region.<\/p>\n\n\n\n

\u201cThe strategic collaborations announced by Globalpharma during \u2018Make it in the Emirates\u2019 reflect the UAE\u2019s commitment to strengthening domestic pharmaceutical manufacturing and reducing reliance on imports. These partnerships embody the core goals of the \u2018Make it in the Emirates\u2019 initiative\u2014empowering local industry, accelerating innovation, and enhancing the country\u2019s position as a global hub for high-quality, future-ready healthcare solutions,\u201d stated His Excellency Dr. Thani Al Zeyoudi, UAE Minister of State for Foreign Trade and Chairman of the Emirates Drug Establishment<\/em>.<\/strong><\/p>\n\n\n\n

“Dubai Investments\u2019 long-term strategy is rooted in enabling sectors that drive national progress, and healthcare is central to that vision. These strategic partnerships by Globalpharma reflect the commitment to advancing the UAE\u2019s industrial capabilities, promoting knowledge transfer, and building a resilient pharmaceutical ecosystem that supports regional health security and innovation-driven growth,” said Mohammed Saeed Al Raqbani, General Manager of Dubai Investments Industries and Masharie and Board Director at Globalpharma.<\/strong><\/em><\/p>\n\n\n\n

Among the signings, PharmaPrimes Laboratories<\/strong>, a leading CRO based in Amman, Jordan, has signed a strategic partnership with Globalpharma to establish advanced local capabilities for batch release and analysis of biosimilar drugs in the United Arab Emirates. This partnership reflects PharmaPrimes\u2019 commitment to strengthening quality infrastructure and providing high-quality, cost-competitive biosimilar therapies across the GCC countries, enhancing the competitiveness of the pharmaceutical sector and improving healthcare quality in the region.<\/p>\n\n\n\n

In another majoragreement, NerhadouInternational<\/strong>, oneofEgypt\u2019sforemost nutraceutical companies,joinedforceswithGlobalpharmatointroduceaportfolioofinnovativenutraceutical and over the counter (OTC) products tailored to regional health needs. The collaboration is expected to reinforce the UAE\u2019s wellness landscape by promoting preventive care and healthier lifestyles.<\/p>\n\n\n\n

Further expanding its footprint in the wellness space, Globalpharma entered a collaboration with Aora Health, a Spanish company <\/strong>known for its science-driven approach to functional supplements. The partnership will see the co-development and local manufacturing of a premium range of preventive health supplements, enabling quicker market access to European-quality wellness products across the UAE and the MENA region.<\/p>\n\n\n\n

Rounding out the series of partnerships, Globalpharma signed a Licensing and Supply Agreement with BioSyent Pharma Inc<\/strong>, a specialty pharmaceutical company committed to improving the lives of patients with unique and effective products in Canada and select international markets. The agreement covers the introduction of FeraMAX\u00ae<\/strong>, a patented oral iron supplement known for its high bioavailability and reduced gastrointestinal side effects.Globalpharma will undertake secondary packaging and marketing of the product within the UAE.<\/p>\n\n\n\n

\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

Globalpharma, the UAE\u2019s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, has signed 4 strategic Memorandums of Understanding (MoUs) during the Make it in the Emirates Forum 2025. The agreements reinforce the UAE\u2019s position as a regional hub for pharmaceutical innovation, localization, and advanced healthcare manufacturing. The MoUs were signed individually […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[4],"tags":[],"class_list":["post-76489","post","type-post","status-publish","format-standard","hentry","category-news"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.middleeastevents.com\/blog\/wp-json\/wp\/v2\/posts\/76489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.middleeastevents.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.middleeastevents.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.middleeastevents.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.middleeastevents.com\/blog\/wp-json\/wp\/v2\/comments?post=76489"}],"version-history":[{"count":1,"href":"https:\/\/www.middleeastevents.com\/blog\/wp-json\/wp\/v2\/posts\/76489\/revisions"}],"predecessor-version":[{"id":76491,"href":"https:\/\/www.middleeastevents.com\/blog\/wp-json\/wp\/v2\/posts\/76489\/revisions\/76491"}],"wp:attachment":[{"href":"https:\/\/www.middleeastevents.com\/blog\/wp-json\/wp\/v2\/media?parent=76489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.middleeastevents.com\/blog\/wp-json\/wp\/v2\/categories?post=76489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.middleeastevents.com\/blog\/wp-json\/wp\/v2\/tags?post=76489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}